News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Investors Commit $172 Million for Development of Ingestible Data Devices to Monitor Effectiveness of Therapeutic Drugs In Vivo

With other companies also advancing ingestible and wearable technology, these new sources of useful diagnostic information may soon become available to pathologists and medical lab professionals

Ingestible sensors are now in the marketplace! These devices are designed to be swallowed by the patient. The device will then send the patient’s vital health data to a smartphone. No imagination is needed by pathologists to understand how such devices could generate diagnostic data in real time that could supplement traditional medical laboratory tests.

These ingestible sensors are designed with the goal of helping track both the adherence of patients to their prescription drug regimens and the effectiveness of these prescription drugs.

Proteus Digital Heath of Redwood City, California, is one company that has introduced an ingestible sensor that sends a person’s vital health data to a smartphone, reported Smart Planet in a story it recently published. (more…)

Experts Predict Shortage of Clinical Laboratory Labor Will Create Need for More Sophisticated Laboratory Information Systems

Recent reports show why labs need more robust laboratory information systems (LIS), including a shrinking workforce, new requirements to connect to EMRs in hospitals and physicians’ offices, and the development of health information exchanges.

Clinical laboratories nationwide are realizing they need new and more powerful laboratory information systems (LIS) as they seek to process larger volumes of medical laboratory tests with a shrinking number of medical technologists and clinical laboratory scientists.

In response to the critical shortages of MTs, CLSs, and other laboratory scientists, most clinical laboratories are beefing up automation in all areas of the lab. From the high-volume core chemistry/hematology laboratory to microbiology and histology, laboratory automation systems are becoming ubiquitous. But all this lab automation increases the need to use information technologies to manage both automation and the flow of specimens through the laboratory.

A report published earlier this year by Kalorama Information of Rockville, Maryland, actually links the shortage of skilled medical laboratory staff as one of the most important factors in fostering growth in the LIS market. Researchers estimated the size of the LIS market at $800 million and predicted that it would grow about 6% annually for the next few years.

As pathologists and clinical laboratory managers know, labor accounts for more than 60% of the cost of producing medical laboratory test results. The Kalorama report stated that laboratory automation and better information management systems can reduce the number of manual procedures and tasks in the typical medical laboratory, In turn, this helps optimize labor efficiency, said the report titled, Laboratory Information Systems (LIS / LIMS) Markets. (more…)

Pathologists Take Note: C. Craig Venter Just Created the First Synthetic Life Form

Milestone achievement may lead to more sophisticated clinical laboratory tests

Now science can create synthetic life forms and J. Craig Venter, Ph.D., is the first to do it. The landmark feat, which involved building the genome of a bacterium from scratch and incorporating it into a cell, “paves the way for designer organisms that are built rather than evolved,” noted the author of an article in

J. Craig Venter, Ph.D., best known to pathologists and clinical laboratory scientists for his role in sequencing the first human genome, achieved the feat at the J. Craig Venter Institute in Rockville, Maryland. Venter and his team synthesized the 1.08 million base pair chromosome of a modified Mycoplasma mycoides genome. The synthetic cell, called Mycoplasma mycoides JCVI-syn1.0, is proof of the principle that genomes can be designed in the computer, chemically made in the laboratory, and transplanted into a recipient cell to produce a new self-replicating cell controlled by the synthetic genome. The experiment demonstrates how fast genetic technologies are advancing.